| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |